Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue Sarcomas
Targeted therapies have revolutionized cancer treatment. It is well established that alterations of chromatin configuration and modifications affect tumorigenesis of some, possibly most, bone and soft-tissue sarcomas. As epigenetic regulators play a major role in the development of bone and soft-tis...
Main Authors: | Jun Wang, Arielle Elkrief, Wei Guo, Neerav Shukla, Mrinal Gounder, Marc Ladanyi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/2021/5575444 |
Similar Items
-
Therapeutic Targets for Bone and Soft-Tissue Sarcomas
by: Shinji Miwa, et al.
Published: (2019-01-01) -
Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
by: Kenji Nakano, et al.
Published: (2018-03-01) -
Bone and Soft Tissue Sarcoma
by: Antonio Ruggiero
Published: (2020-09-01) -
Soft Tissue and Bone Sarcoma
Published: (2014) -
Bone tumor and soft tissue sarcomas
by: Reynaldo Jesus Garcia Filho
Published: (2008-03-01)